Prescience Insilico is a pioneering deep tech company harnessing the power of artificial intelligence (AI) and machine learning to accelerate drug and materials discovery and development. Our innovative platform, PRinS3, is designed to streamline these processes by seamlessly integrating data from diverse sources.
Our Mission
We aspire to democratize AI-augmented computational modeling and simulations, driving the industrial revolution in smart materials and expediting drug development.
The Role of AI in Scientific Innovation
AI is emerging as the fourth pillar of scientific innovation, complementing experimentation, theory, and modeling (simulations). Scientific breakthroughs begin with assumptions, followed by preliminary experiments and theoretical frameworks. By fine-tuning these experiments through a deep understanding of underlying mechanisms—where modeling plays a crucial role—scientists can enhance their research outcomes. At Prescience, we integrate these four pillars into our R&D pipeline, developing user-friendly technologies tailored for the materials and drug industries.
Key Advantages
One of the standout features of Prescience Insilico's technology is its capacity to analyze vast datasets and uncover patterns that may not be immediately recognizable to human researchers. This capability facilitates the identification of new drug targets, potential drug candidates, and innovative materials that traditional discovery methods might overlook.
Transforming Research and Innovation
Prescience is revolutionizing research and innovation across multiple industries through:
•	Computational R&D: Leveraging advanced algorithms for enhanced discovery.
•	Digital Twins: Utilizing digital twins for formulation efficacy testing.
•	Physics-Informed Machine Learning Models: Driving digital transformation in materials science.
•	AI-Powered Drug Discovery: Enhancing materials optimization and accelerating drug development timelines.

Prescience Insilico

Org chart

Teams

Offices